Vanessa L. Ford

Array ( [id] => 8927563 [patent_doc_number] => 20130183323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'TARGETED ANTIBIOTIC AND ANTIMICROBIAL TREATMENTS FOR PERSONALIZED ADMINISTRATION' [patent_app_type] => utility [patent_app_number] => 13/720934 [patent_app_country] => US [patent_app_date] => 2012-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5508 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13720934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9864143 [patent_doc_number] => 20150044162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-12 [patent_title] => 'ANTICANCER FUSION PROTEIN' [patent_app_type] => utility [patent_app_number] => 14/361279 [patent_app_country] => US [patent_app_date] => 2012-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 48585 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14361279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8828721 [patent_doc_number] => 20130129766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'RECOMBINANT PLASMODIUM FALCIPARUM MEROZOITE SURFACE PROTEINS 4 AND 5 AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 13/666601 [patent_app_country] => US [patent_app_date] => 2012-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 22190 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13666601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8516240 [patent_doc_number] => 20120315648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'METHOD OF IDENTIFICATION OF CELLS THAT SHOW SENSITIVITY TO MODULATION OF SIGNALING MEDIATED BY A FIBROBLAST GROWTH FACTOR RECEPTOR OR A VARIANT THEREOF' [patent_app_type] => utility [patent_app_number] => 13/592709 [patent_app_country] => US [patent_app_date] => 2012-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16864 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13592709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9081900 [patent_doc_number] => 20130267430 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2013-10-10 [patent_title] => 'METHOD AND REAGENT FOR DIAGNOSIS AND/OR EVALUATION OF PROGRESSION OF GRAFT-VERSUS-HOST DISEASE' [patent_app_type] => utility [patent_app_number] => 13/523791 [patent_app_country] => US [patent_app_date] => 2012-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 8649 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13523791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9081900 [patent_doc_number] => 20130267430 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2013-10-10 [patent_title] => 'METHOD AND REAGENT FOR DIAGNOSIS AND/OR EVALUATION OF PROGRESSION OF GRAFT-VERSUS-HOST DISEASE' [patent_app_type] => utility [patent_app_number] => 13/523791 [patent_app_country] => US [patent_app_date] => 2012-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 8649 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13523791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776386 [patent_doc_number] => 20120039919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'DIABETES DIAGNOSTIC, PROPHYLACTIC, AND THERAPEUTIC COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/204357 [patent_app_country] => US [patent_app_date] => 2011-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 23017 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039919.pdf [firstpage_image] =>[orig_patent_app_number] => 13204357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6087854 [patent_doc_number] => 20110217287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'Therapeutic composition comprising a botulinum neurotoxin' [patent_app_type] => utility [patent_app_number] => 13/068439 [patent_app_country] => US [patent_app_date] => 2011-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3534 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217287.pdf [firstpage_image] =>[orig_patent_app_number] => 13068439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586468 [patent_doc_number] => 20110280978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'COSMETIC USE OF BOTULINUM TOXIN FOR THE TREATMENT OF EYEBROW AND FOREHEAD PTOSIS, AND UNWANTED EYEBROW EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/943294 [patent_app_country] => US [patent_app_date] => 2010-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3254 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280978.pdf [firstpage_image] =>[orig_patent_app_number] => 12943294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055119 [patent_doc_number] => 20110111479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Botulinum Neurotoxin Serotype B Activatable Botulinum Neurotoxin Serotype Bs' [patent_app_type] => utility [patent_app_number] => 12/871585 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 90841 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20110111479.pdf [firstpage_image] =>[orig_patent_app_number] => 12871585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8185311 [patent_doc_number] => 20120115205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'Botulinum Neurotoxin Serotype B Activatable Botulinum Neurotoxin Serotype Bs' [patent_app_type] => utility [patent_app_number] => 12/871486 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 90835 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115205.pdf [firstpage_image] =>[orig_patent_app_number] => 12871486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6237431 [patent_doc_number] => 20100267931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'HETEROLOGOUS EXPRESSION OF NEISSERIAL PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/825210 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 35744 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267931.pdf [firstpage_image] =>[orig_patent_app_number] => 12825210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6347703 [patent_doc_number] => 20100330661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'Peptides for Detection of Antibody to Ehrlichia ewingii' [patent_app_type] => utility [patent_app_number] => 12/824781 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9800 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330661.pdf [firstpage_image] =>[orig_patent_app_number] => 12824781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527597 [patent_doc_number] => 08044189 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Bacillus anthracis protective antigen nucleic acid sequences' [patent_app_type] => utility [patent_app_number] => 12/816285 [patent_app_country] => US [patent_app_date] => 2010-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 10691 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/044/08044189.pdf [firstpage_image] =>[orig_patent_app_number] => 12816285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234934 [patent_doc_number] => 20100266638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'HEADACHE TREATMENT METHOD' [patent_app_type] => utility [patent_app_number] => 12/793603 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 40820 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266638.pdf [firstpage_image] =>[orig_patent_app_number] => 12793603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6582308 [patent_doc_number] => 20100291138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Vaccine' [patent_app_type] => utility [patent_app_number] => 12/793408 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21840 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291138.pdf [firstpage_image] =>[orig_patent_app_number] => 12793408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148792 [patent_doc_number] => 20110020387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'MALARIA VACCINE' [patent_app_type] => utility [patent_app_number] => 12/793575 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12376 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020387.pdf [firstpage_image] =>[orig_patent_app_number] => 12793575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231508 [patent_doc_number] => 20100184689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Pharmaceutical Composition Containing Botulinum Neurotoxin' [patent_app_type] => utility [patent_app_number] => 12/748733 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8035 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184689.pdf [firstpage_image] =>[orig_patent_app_number] => 12748733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6418447 [patent_doc_number] => 20100167393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'MODIFIED HUMAN THYMIC STROMAL LYMPHOPOIETIN' [patent_app_type] => utility [patent_app_number] => 12/723499 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12675 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20100167393.pdf [firstpage_image] =>[orig_patent_app_number] => 12723499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7686074 [patent_doc_number] => 20100120067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'H. Meleagridis Assay' [patent_app_type] => utility [patent_app_number] => 12/617420 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6218 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120067.pdf [firstpage_image] =>[orig_patent_app_number] => 12617420 [rel_patent_id] =>[rel_patent_doc_number] =>)